Abstract
The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.
| Original language | English |
|---|---|
| IPC | A61K39/04 |
| Patent number | WO2014114812 |
| Filing date | 31/07/2014 |
| Country | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 28/01/2013 |
| Priority number | EP20130152908 |
| Publication status | Published - 2014 |
Cite this
Jungersen, G., Thakur, A., Aagaard, C., Andersen, P., & Melvang, H. M. (2014). IPC No. A61K39/04. A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine. (Patent No. WO2014114812).